Compare CTSO & IPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTSO | IPWR |
|---|---|---|
| Founded | 1997 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.7M | 39.9M |
| IPO Year | 2008 | 2013 |
| Metric | CTSO | IPWR |
|---|---|---|
| Price | $0.77 | $3.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $5.38 | ★ $10.75 |
| AVG Volume (30 Days) | 67.5K | ★ 84.6K |
| Earning Date | 01-01-0001 | 06-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $22,503,908.00 | N/A |
| Revenue This Year | $7.29 | $2,603.56 |
| Revenue Next Year | $8.91 | $1,800.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 48.53 | N/A |
| 52 Week Low | $0.60 | $2.62 |
| 52 Week High | $1.39 | $6.90 |
| Indicator | CTSO | IPWR |
|---|---|---|
| Relative Strength Index (RSI) | 50.01 | 49.87 |
| Support Level | $0.62 | $2.91 |
| Resistance Level | $0.74 | $4.35 |
| Average True Range (ATR) | 0.04 | 0.35 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 45.95 | 54.13 |
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.